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Abstract
Background: Mental health is a significant contributor to global burden of disease and the consequences of
perinatal psychiatric morbidity can be substantial. We aimed to obtain global estimates of puerperal psychosis
prevalence based on population-based samples and to understand how postpartum psychosis is assessed and
captured among included studies.
Methods: In June 2014, we searched PubMed, CiNAHL, EMBASE, PsycINFO, Sociological Collections, and Global Index
Medicus for publications since the year 1990. Criteria for inclusion in the systematic review were: use of primary data
relevant to pre-defined mental health conditions, specified dates of data collection, limited to data from 1990 onwards,
sample size >200 and a clear description of methodology. Data were extracted from published peer reviewed articles.
Results: The search yielded 24,273 publications, of which six studies met the criteria. Five studies reported incidence of
puerperal psychosis (ranging from 0.89 to 2.6 in 1000 women) and one reported prevalence of psychosis (5 in 1000).
Due to the heterogeneity of methodologies used across studies in definitions and assessments used to identify cases,
data was not pooled to calculate a global estimate of risk.
Conclusions: This review confirms the relatively low rate of puerperal psychosis; yet given the potential for serious
consequences, this morbidity is significant from a global public health perspective. Further attention to consistent
detection of puerperal psychosis can help provide appropriate treatment to prevent harmful consequences for both
mother and baby.
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Background
As a tragic but rare event, maternal mortality accounts
for a small fraction of the overall burden of poor maternal
health. Maternal morbidity, the health problems borne by
women during pregnancy, childbirth and the postpartum
period, also contributes to this burden in a major way.
Measuring the burden of pregnancy and related post-
partum morbidity is crucial to achieving the health and
development goals articulated in the Sustainable Develop-
ment Goals (SDGs) and those of the Global Strategy for
Women’s, Children’s, and Adolescent health [1, 2]. The se-
verity, occurrence, and timing of maternal conditions
causing morbidity, and the measurement of their impact
on women’s life, are key issues in the conceptualization of
maternal morbidity.
To date, there has not been valid, routine, and com-
parable measurements of maternal morbidity [3]. To ad-
dress this gap, the World Health Organization’s (WHO)
Department of Reproductive Health and Research (RHR)
introduced an initiative, led by a Maternal Morbidity
Working Group (MMWG), composed of technical experts
in maternal and women’s health, epidemiology, public
health (including researchers and clinicians), program
managers and consumer representatives, to estimate the
burden of maternal morbidity based on existing evidence,
and develop standard measures for maternal morbidity
[4], in order to reflect the full continuum of maternal
morbidity, including non-severe morbidity [5]. Several
systematic reviews are being conducted as part of this ini-
tiative, including reviews on the prevalence of conditions
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included in the definition of maternal morbidity. The sys-
tematic reviews aim to provide recent epidemiological evi-
dence for maternal conditions of high priority to support
the implementation of maternal and neonatal health pro-
grams. As part of this effort, the MMWG recognized ma-
ternal mental health as a key area of study. This specific
review will focus on the global prevalence of postpartum
psychosis for reasons discussed further below.
Mental health is a significant contributor to global
burden of disease. WHO estimates that for women of re-
productive age (15–49), mental and behavioral disorders
accounted for approximately 64 million global Disability
Adjusted Life Years (DALYs) lost between 2000 and
2012 [6]. This burden also appears to be increasing over
time. Between 2000 to 2012, mental and behavioral dis-
orders increased from 5.9% to 7.3% as a proportion of
all-cause DALYs [6]. Together these conditions are the
fifth leading disorder category of DALYs and the leading
global cause of all non-fatal burden of disease [6, 7].
Across all regions, girls and women are disproportion-
ately affected compared to boys or men; the prevalence
of depression among women is approximately two times
greater than among men [8]. The highest proportion of
DALYs for women occurs during key reproductive-age
years. These findings highlight the importance of consid-
eration for perinatal (i.e. timeframe just before and after
birth) psychiatric morbidity. On average, 10% of preg-
nant women and 13% of postpartum women experience
some type of mental disorder, most commonly depres-
sion or anxiety [9–11]. Prevalence rates have been found
to be even greater in low and middle-income countries
(LMICs), with average prevalence of about 16% ante-
natally and almost 20% postnatally [9].
The consequences of perinatal psychiatric morbidity
can be substantial. Perinatal mental disorders are also
associated with maternal complications and an increased
risk of adverse neonatal and developmental outcomes
for the child [12]. The severity of consequences can be
heightened in the presence of comorbidities for the mother
[13]; and comorbidities are increasing in pregnancy [14]. A
recent systematic review focused on prevalence of com-
mon, non-psychotic perinatal mental disorders in low and
middle-income countries (LMICs) [9]. Due to the poten-
tially detrimental consequences of psychosis during the
perinatal period, a systematic review on the prevalence
of perinatal psychosis is warranted.
The current psychiatric nosology in the Diagnostic and
Statistical Manual of Mental Disorders (DSM-5) does not
recognize postpartum psychosis as a distinct disorder;
rather, if a woman meets criteria for a brief psychotic
disorder, the DSM-5 suggests adding “with postpartum
onset” as a specifier if the onset is during pregnancy or
within 4 weeks postpartum [15]. Some clinicians believe
that the timeframe for the postpartum specifier should
be extended to 6 months after delivery based on clinical
experience suggesting that episodes can present beyond
the 4 weeks [15]. As psychosis during the perinatal period
typically occurs within the first 4 weeks of the postpartum
period [16], this review will focus on postpartum psychosis
as opposed to perinatal (which generally includes the
ante- and intra-partum periods) psychosis more broadly.
Clinical features of postpartum psychosis include elated,
dysphoric or labile mood, agitation, bizarre or disorganized
behavior and thought processes, and insomnia, while
psychotic symptoms can often include mood-incongruent
delusions, hallucinations, or delusions of control, with
content often related to the infant or self (e.g., harm to
the infant or self ) [15]. Though postpartum psychosis is
relatively uncommon when compared to other mental
disorders, the acuity and gravity of its consequences such
as suicide or infanticide warrants specific attention [17].
Postpartum psychosis can increase risk for future non-
pregnancy related psychotic episodes [18] and is a critical
indicator of an underlying diagnosis of bipolar disorder
[16, 19]. Improved detection of puerperal psychosis, a
likely first indicator of an underlying diagnosis of bipolar
disorder, could lead to proper diagnosis and treatment of
bipolar disorder for perinatal women [20, 21].
Although a variety of evidence based treatment op-
tions exist for perinatal women, the rate of treatment
for mental health disorders among perinatal women is
low [22]. For example, less than 15% of women in an
obstetrics clinic who scored above a cut-off for depres-
sion reported receiving any formal treatment [23]. Bar-
riers to treatment can include factors such as limited
resources or insurance to cover costs of treatment,
time demands, transportation, stigma associated with
treatment, or lack of knowledge regarding where to
seek treatment [22, 24]. The treatment gap for mental
health is significant, particularly in developing coun-
tries [25]. A first step towards addressing the treat-
ment gap will be appropriate screening and monitoring
of global perinatal mental health. In order to accur-
ately monitor a given disorder, robust estimates of
prevalence are needed, which this current systematic
review will address.
Few reviews on the prevalence of common mental
disorders in the perinatal period have focused on rare
or more severe mental disorders, such as psychosis, on
a global scale. The most frequently cited prevalence of
puerperal psychosis is 1–2 per 1000 childbirths [26]. How-
ever, this estimate was determined in a developed country
setting (Edinburgh in 1987) and is potentially out of date
and not generalizable. The purpose of this systematic re-
view is thus to obtain up-to-date global estimates of puer-
peral psychosis prevalence based on population-based
samples and to understand how postpartum psychosis is
being assessed and captured among the included studies.
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Methods
The protocol for all the systematic reviews associated with
the maternal morbidity initiative was adapted from the
peer-reviewed methodology established for the WHO Sys-
tematic Review of Maternal Morbidity and Mortality [27].
Both the search strategy and inclusion criteria, which have
been described elsewhere, were tailored for the purposes
of this review [27, 28]. Data for this study were identified
by searches of PubMed, CiNAHL, EMBASE, PsycINFO,
Sociological Collections, and Global Index Medicus and
references from relevant articles with the search terms in-
cluding “pregnancy”, “mothers”, “postpartum”, “epidemio-
logic methods”, “mood disorders”, “anxiety disorders”,
“psychosis”, and “schizophrenia”. Search terms were modi-
fied for each of the databases by a librarian at the WHO
headquarters in Geneva, Switzerland. See Additional file 1
for example search strategy of one database. We focused
on publications irrespective of language since the year
1990 and the search was conducted in June 2014. Criteria
for inclusion of studies in the review were: inclusion of
primary data relevant to pre-defined mental health condi-
tions, specified dates for data collection period, limited to
data from 1990 onwards, sample size >200 and a clear de-
scription of methodology. While the onset of postpartum
psychosis typically occurs within the first month after de-
livery, there is inconsistency in the field of what consti-
tutes the postpartum timeframe for maternal morbidities
[29], so the search included any articles referencing the
“postpartum” period. All appropriate study designs (i.e.,
cross-sectional, cohort/longitudinal, controlled trial, inci-
dence/prevalence survey, case-control) were included; for
case-control studies, the sample size of the cases arm had
to be over 200. Additionally, we sought summary esti-
mates and not individual level patient data.
Over 24,000 reports were screened (by RV & MB) ini-
tially by titles and/or abstracts of which almost 23,000
were excluded upon initial title and/or abstract screen.
Of the remaining approximately 1000 reports, almost
700 were included upon rescreening (by RV &MB) to be
retrieved for full-text review. In a 2-step process, the
same two reviewers independently determined whether
studies met inclusion criteria. In step 1, each reviewer
assessed and categorized abstracts of articles as “in-
cluded,” “unsure,” or “excluded.” Discrepancies were re-
solved by consensus; a third reviewer (DC) adjudicated
unresolved disputes and the judgment of this third re-
viewer was considered final. Based on title and abstract,
we then categorized articles by conditions covered in the
study (e.g. depression, anxiety, psychosis, etc.). For the
purposes of this review, we focused on articles that in-
cluded psychosis prevalence or incidence data as discussed
in the introduction. If the conditions discussed in a given
article were unclear or unstated, the full text was pulled to
determine whether or not there was psychosis prevalence
data. Efforts to pull all full text articles were made in con-
junction with the WHO librarian and diverse WHO Head-
quarter staff fluent in the article languages, and for
translation to relevant languages were made when possible.
As an effort to ensure that all relevant studies were
captured for our review, we additionally conducted a sci-
ence citation index search on the previously mentioned,
keystone article by Kendell et al. [26] that has been the
primary reference for prevalence of puerperal psychosis
since its publication. A total of 566 citations were identi-
fied using Web of Science. We exported titles and ab-
stracts for these articles and conducted a screening as
described above to identify any articles meeting criteria
for inclusion and/or data extraction that required full
text review. Despite our efforts to include all articles re-
gardless of location and language of publication, there
may be a risk of publication bias in the studies identified
and included in our review, in that studies written in a
certain language or reporting certain findings may be
more likely to be published than others.
The selection process was repeated until all articles
were ultimately categorized as included or excluded.
Screening title and abstracts, 92 were identified to report
on psychosis and pulled for full text review. Following
full-text review, 6 articles were included for this system-
atic review (see Table 1 for eligibility exclusion reasons).
See Fig. 1 for flow of the article search, screening, and
review, following PRISMA guidelines (and see Add-
itional file 2 for the PRISMA Checklist). T1
A data extraction instrument was used to obtain data
from included studies. This instrument is composed of 40
items distributed in five modules, three of which were
relevant to this review. Modules were designed to collect
information on (i) the general study level characteristics
such as design, population, setting, (ii) prevalence/inci-
dence of psychological conditions, and (iii) quality assess-
ment of reports. Reporting of definitions and of the
procedures used for identification of cases was part of
quality assessment. For quality appraisal, we extracted in-
formation on study design, sampling method, sources of
data, completeness of follow-up or records, reported defi-
nitions and diagnostic procedures regarding outcomes.
The evaluation of methodological and reporting quality
was used to assess the reliability and accuracy of the data
as objectively as possible, and has been described else-
where [27]. Each paper was assessed for quality adequacy
on four criteria and rated on a score of 1 (high – all four
criteria are adequate) to 3 (low – none or only one criter-
ion is adequate). Both RV and MB conducted separate
quality reviews of each of the 6 articles; any differences
were discussed and a final decision was made. (Please see
Additional file 3 for complete quality assessment criteria.)
The same two reviewers (RV & MB) independently ex-
tracted data from each article using the data extraction
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form. See Additional file 4 for data extraction form used.
A third party (DC) resolved disagreement in the same
manner as for study inclusion. Given the diversity in the
study design, measurement tools and definitions used, a
meta-analysis of the findings was not performed. Below,
we describe the included studies with an emphasis on
the prevalence reported and criteria for identification of
the cases. While the aim of our search was to capture
prevalence data, as mentioned in the background, the
majority of included studies reported on incidence of
puerperal psychosis.
The funder of the study had no role in study design,
data collection, data analysis, data interpretation, or
writing of the report. The corresponding author had full
access to all the data in the study and had final responsi-
bility for the decision to submit for publication.
Results
The systematic search yielded a total of six studies that
met the screening criteria described above (see Table 2).
Three of the studies involved reviews of national birth
registries (Nager, Terp, Valdimarsdóttir), while a fourth
employed data from a nationally representative household-
level survey (Vesga-Lopez). These studies were conducted
in Sweden (Nager and Valdmirsdóttir), Denmark (Terp)
and the United States (Vesga-Lopez). As for the remaining
two studies, one was conducted at a tertiary teaching
institution in Ogun state, Nigeria and the other, at the
community level in Maharashtra state, India, (Adefuye
and Bang, respectively).
Four of the studies employed retrospective methods
extracting information from the national birth registry
(Valdimarsdóttir), national birth and psychiatric registries
(Terp), national birth and hospital discharge registers
(Nager), or women’s medical records (Adefuye) in order
to calculate incidence. Vesga-Lopez utilized data from the
United States National Epidemiologic Survey on Alcohol
Fig. 1 PRISMA Flow Diagram. From: Moher et al. [46]
Table 1 Breakdown for Exclusion Reasons at “Eligibility” Stage
Exclusion Reason Number of Articles
Excluded
No psychosis prevalence data 41
Review or editorial (i.e. not empirical study) 16
Duplicate article 8
Sample size <200 6
Not general population 5
Dates of data collection/publication 4
Not able to access article 4
Other 2
TOTAL 86
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and Related Conditions survey, which gathered data
from face-to-face interviews conducted in households
across all 50 states and the District of Columbia to
estimate prevalence. Bang et al. describes the only
observational study that met the inclusion criteria,
whereby community health workers visited a woman
at home and assessed her condition (a physician val-
idated the information and diagnosis was made by a
computer program). One other study (Okano, 1998)
fit our criteria [30], however it was not included in
this review due to unclear methodology for preva-
lence calculations. Additionally, various studies pre-
sented above collected data prior to 1990; however
in each case, authors were contacted and did not
respond to email queries about either calculation
methods nor data disaggregation, respectively. Given
that the articles without disaggregated data were of
high quality, they were included, although the Okano
article was not included as the authors found the lack
of transparency in calculations a major flaw.
Three studies, Nager, Terp and Valdimarsdóttir, ex-
tracted the women’s psychosis diagnoses from her re-
cords, as completed by a medical professional in
national birth registries using International Classifica-
tion of Diseases (ICD) coding. Terp also used admis-
sion information from hospital records from the Danish
Psychiatric Central Register while Nager employed data
from the Swedish national discharge register, both of
which applied ICD codes for diagnosis. The Vesga-
Lopez study, which drew from the national health sur-
vey of households in the United States, asked women
to indicate whether a doctor or other medical profes-
sional had ever diagnosed her with schizophrenia or a
psychotic disorder. Adefuye and Bang used women’s
medical records or community health workers making
home visits, respectively, to attain a diagnosis; the stud-
ies fail to detail the coding or diagnosis instruments
used by the medical professional or community health
workers to assess the woman’s psychotic state.
Most included studies reported on incidence (n = 5)
and one study reported prevalence rates. Puerperal
psychosis prevalence or incidence was assessed at vari-
ous perinatal timeframes across the included studies.
Most studies included only the postpartum period, but
this timeframe varied across studies from a 2–32 day
range [31], to up to a year postpartum [32]. One study
compared incidence rates between two different post-
partum time periods, breaking postpartum psychosis
incidence down into two categories: within 90 days
postpartum and after 90 days postpartum [33]. One
study also included the pregnancy time period [34], al-
though both of the psychosis cases reported in this
study occurred during the puerperium period, and
were associated with adverse perinatal outcomes.
The reported incidence of perinatal psychosis among
our included studies ranged from 0.89 to 2.6 in 1000
women, aligning with the commonly reported preva-
lence rate of 1–2 per 1000 [26]. Terp et al. reported
the lowest incidence (0.89 in 1000) in the study that
had the greatest sample size (over 1.25 million), and
assessed the time period of within 3 months postpar-
tum. Of the six included studies in this review, Vesga-
Lopez (2008) was the only study that reported preva-
lence of postpartum psychosis (5 in 1000). It is worth
mentioning that the cases of psychotic disorder for this
study were self-reported (“psychotic disorders were
indicated by asking the respondent if she was ever told
by a doctor or other health professional that she had
schizophrenia or a psychotic disorder”). Additionally,
the timeframe covered the entire year postpartum,
which may also factor into the higher prevalence
found. The sample size for Vesga-Lopez (2008) was the
second smallest of our included studies, including 994
women. The study that reported the highest incidence
rate (2.6 in 1000) was from Bang et al. [34], which the
smallest sample size of our included studies (N = 772).
The prevalence estimate was higher than any of the in-
cidence estimates. Among the incidence studies, the
highest estimates were among those studies with smaller
sample sizes. However, given the limited number of
studies included in this review, we are not able to draw a
strong conclusion on how estimates differ by method-
ologies or sample sizes.
Discussion
Our review found that post-partum psychosis incidence
ranged between 0.89 and 2.6 in 1000 births across sev-
eral countries, and one study reported prevalence to be
5 in 1000 births. These incidence estimates appear to be
relatively consistent with the frequently cited prevalence
of 1–2 in 1000 births for postpartum psychosis in the
general population [26]. However, due to the wide vari-
ation in definitions and assessments used to capture cases
of postpartum psychosis, it was not possible to pool data
and make a summary estimate. There was inconsistency
with instruments and methods used, as well as differing
timeframes for assessment, to capture and identify post-
partum psychosis. Such variation presents a challenge for
obtaining an accurate estimate of the global burden of
puerperal psychosis or to compare estimates among coun-
tries. Because of the varying methods of case identification
criteria, as well as the limited number of studies that met
our inclusion criteria, it is difficult to make cross-country
comparisons of puerperal psychosis estimates. We cannot
conclude that the incidence of postpartum psychosis is
higher in studies conducted in less developed country
settings, as there is not sufficient variability in the types
of countries included in our review.
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Furthermore, these findings highlight the lack of a
concrete and consistent timeframe used to assess
puerperal psychosis in the literature. By definition,
postpartum psychosis occurs very shortly after birth,
usually within days but up to a month postpartum
[35]. However, several of the included studies assessed
for psychosis well beyond this postpartum period, thus
raising the question of whether or not these were true
cases of puerperal psychosis.
Our search methodology includes some limitations
that are important to consider when drawing conclusions
from this study. First, we conducted a search of literature
published within the past 15 years according to estab-
lished WHO systematic review guidelines with the aim
of including only the most recent studies. However, this
excluded a number of rigorously conducted studies on
puerperal psychosis that were published prior to this
date [19, 26, 36]. Secondly, as we were interested in
population-level estimates, and due to previously reported
rare occurrence of postpartum psychosis, we only in-
cluded studies that had a sample sizes of greater than 200.
Thus, a number of studies were excluded due to small
sample size. Although appropriate sample sizes for sys-
tematic reviews have been debated, there is evidence that
small size studies are less likely to be published and inclu-
sion of small studies may consequently introduce effects
of publication bias [37]. Additionally, while Adefuye et al.
present hospital based data, we felt it important to include
given that while not representative of the entire Nigerian
population, it represents data that are rare to find in the
African region. The manuscript by Bang et al., though not
representative of the entire Bangladeshi population in-
cludes a large and diverse catchment area, and again rep-
resents the only data found for the Asian region. Another
limitation is that we did not assess the time of onset for
the cases of postpartum psychosis across all included
studies. A clinical feature of postpartum psychosis is rapid
onset within the first month of delivery [15], yet some of
the included studies considered the postpartum period to
be up to 1 year after delivery. Thus, the estimates of post-
partum psychosis in this review may reflect cases of onset
beyond the first month following delivery.
A key strength of our systematic review is its compre-
hensive search strategy with over 24,000 papers screened.
As part of the larger initiative to measure the burden of
specific maternal morbidities, in order to follow the
protocol for systematic reviews, we focused on pub-
lished peer-reviewed articles with primary data collec-
tion. While it is a limitation that we did not carry out a
grey literature search, we did attempt to expand our
scope through the additional citation search of the key-
stone article by Kendell et al. [26]. Additionally, although
we assessed quality of the studies, all publications relevant
to our study aim in this review were included if they met
inclusion criteria. Therefore, a bias may have been intro-
duced in reporting findings in the studies of poor quality.
While this review focused on estimates among a gen-
eral population, prevalence among at-risk populations
may be greater and also clinically meaningful. For ex-
ample, one study on teenagers found 2.5% prevalence
[38] and another found a significantly higher rate (15%)
for women with history of major affective disorder [39].
Such higher risk populations were outside of the scope
of this current review but highlight that additional atten-
tion may be needed not just to pregnant women but also
to pregnant women who are identified as at-risk.
There may be further cultural aspects of the preva-
lence and identification of puerperal psychosis that were
beyond the scope of this review, but remain an import-
ant area for further investigation. For example, the afore-
mentioned Okano et al. [30] study reported a low rate of
puerperal psychosis. The authors suggested that there
may be social and cultural factors that underlie lower
rates of perinatal psychiatric illness in Japan [30]; citing
the Japanese custom known as Satogaeri bunben, where
the mother returns to her parental home for up to
2 months postpartum, as a factor in significantly redu-
cing stress post childbirth. Alternatively, some believe
that the relatively high stigma associated with mental
illness in Japan may result in lower rates of diagnosis
[40]. An area for future research that was beyond the
scope of this review is with regards to how the presen-
tation and identification of puerperal psychosis and its
related stigma may differ across cultural contexts, and
implications for measuring prevalence.
Although this systematic review confirms the relatively
low rate of puerperal psychosis, given the potential for
serious consequences associated with puerperal psychosis,
even a low rate becomes a significant public health issue
from a global perspective. As discussed previously, there
can be tragic consequences such as suicide or infanticide
[17]. Suicide has been identified as a leading cause of ma-
ternal death in some developed countries [41] and is also
a leading cause of death in reproductive-aged women in
the world’s two most populous countries, India and China
[42]. For example, considering a country such as China
where there are approximately 16 million births a year,
there could potentially be up to 32,000 cases of puerperal
psychosis within that same time period in just this country
alone, at the incidence rate of 2 cases per 1000 childbirths
among the general population.
Postpartum psychosis can also serve as a valuable first
indicator of an underlying diagnosis of bipolar disorder
[16] and can increase risk for future non-pregnancy
related psychotic episodes [18]. The highest lifetime risk
for first onset and recurrent episodes of bipolar disorder
has been found in the postpartum period [18, 26].
Further attention to the detection and treatment of
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puerperal psychosis can help provide the woman with
appropriate treatment that may prevent the possible
detrimental consequences for both mother and infant
associated with puerperal psychosis.
Conclusions
This review confirms the relatively low rate of puerperal
psychosis; yet the paucity of studies that meet our eligi-
bility criteria highlights the critical gap in knowledge of
puerperal psychosis prevalence from large-scale studies
worldwide. As described above, postpartum psychosis is
a key marker for the risk of future affective disorder,
which is significant contributor to the global burden of
disease [7, 43]. We recommend that further attention be
given to identifying puerperal psychosis and monitoring
incidence more consistently on a global scale. Appropriate
detection of puerperal psychosis is needed to increase
chances that a women will receive adequate treatment,
which could help to mitigate the global disease burden
and improve maternal and newborn health.
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